Del Giudice Matthew Paul 4
4 · MIRA PHARMACEUTICALS, INC. · Filed Jun 15, 2026
Research Summary
AI-generated summary of this filing
MIRA Director Del Giudice Receives 50,000 Stock Options
What Happened
Matthew Paul Del Giudice, a director of Mira Pharmaceuticals, was granted 50,000 stock options on June 12, 2026. The Form 4 lists the acquisition as a derivative grant with a reported dollar amount of $0.00 because the option exercise price equals the closing market price on the grant date ($0.94 per share).
Key Details
- Transaction date: June 12, 2026; Form 4 filed June 15, 2026 (timely within required business-day window).
- Grant: 50,000 stock options, exercise price $0.94 per share (F1, F3). Form reports acquisition value $0.00.
- Vesting: 50% vests on the six-month anniversary and the remaining 50% vests on the one-year anniversary of the grant date (F2, F3).
- Plan: Issued under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (F2).
- Shares owned after transaction: Not specified in the provided filing.
- Filing timeliness: Reported on 2026-06-15 for a 2026-06-12 grant; this filing date is within the usual two-business-day Form 4 deadline.
Context
This was a standard option grant to a director, not an exercise or sale. Because the exercise price matches the market close on the grant date, the options had no intrinsic value at issuance (hence $0 reported). Options will only have economic value if the stock rises above $0.94 before or at exercise.
Insider Transaction Report
- Award
Stock Options (right to buy)
[F1][F2][F3]2026-06-12+50,000→ 50,000 totalExercise: $0.94Exp: 2036-06-12→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026.
- [F2]The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.
- [F3]Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each.